Cargando…

Use of comorbidity indices in patients with any cancer, breast cancer, and human epidermal growth factor receptor-2-positive breast cancer: A systematic review

OBJECTIVE: To identify comorbidity indices that have been validated in cancer populations, with a focus on breast cancer and human epidermal growth factor receptor-2-positive (HER2+) breast cancer. STUDY DESIGN AND SETTING: A systematic review of the literature on the use of comorbidity indices in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salas, Maribel, Henderson, Mackenzie, Sundararajan, Meera, Tu, Nora, Islam, Zahidul, Ebeid, Mina, Horne, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213062/ https://www.ncbi.nlm.nih.gov/pubmed/34143813 http://dx.doi.org/10.1371/journal.pone.0252925

Ejemplares similares

Discrepancies in ICD-9/ICD-10-based codes used to identify three common diseases in cancer patients in real-world settings and their implications for disease classification in breast cancer patients and patients without cancer: a literature review and descriptive study
por: Tu, Nora, et al.
Publicado: (2023)

Health-related quality of life in women with breast cancer: a review of measures
por: Salas, Maribel, et al.
Publicado: (2022)

Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review
por: Hackshaw, Michelle D., et al.
Publicado: (2021)

Validated Instruments of Quality of Life (QOL) in Patients With Acute Myeloid Leukemia (AML) and Other Cancers
por: Salas, Maribel, et al.
Publicado: (2020)

Epidermal Growth Factor Receptors and Breast Cancer
por: Farndon, J. R., et al.
Publicado: (1989)

Comorbidities and their management in women with breast cancer—an Australian survey of breast cancer survivors
por: Koczwara, Bogda, et al.
Publicado: (2023)

Is There Any Cardiovascular Concern Regarding the Use of Aromatase Inhibitors in Breast Cancer?
por: Galvão, Tatiana F. G.
Publicado: (2019)

Cancer and comorbidity: The role of leptin in breast cancer and associated pathologies
por: Ray, Amitabha
Publicado: (2018)

The epidermal growth factor receptor family in breast cancer
por: Koutras, Angelos K, et al.
Publicado: (2008)

Network based systems biology approach to identify diseasome and comorbidity associations of Systemic Sclerosis with cancers
por: Islam, Md Khairul, et al.
Publicado: (2022)

Radiologists can detect the ‘gist’ of breast cancer before any overt signs of cancer appear
por: Brennan, Patrick C., et al.
Publicado: (2018)

Are there any differences between features of proteins expressed in malignant and benign breast cancers?
por: Ebrahimi, Mansour, et al.
Publicado: (2010)

Impact of Undetected Comorbidity on Treatment and Outcomes of Breast Cancer
por: Griffiths, Robert I., et al.
Publicado: (2014)

Anxiety and Depression Comorbidities in Moroccan Patients With Breast Cancer
por: El kherchi, Ouassil, et al.
Publicado: (2021)

Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue.
por: Dittadi, R., et al.
Publicado: (1993)

Tyrosine kinase signalling in breast cancer: Epidermal growth factor receptor and c-Src interactions in breast cancer
por: Biscardi, Jacqueline S, et al.
Publicado: (2000)

Is There any Concordance between of IHC with FISH in HER2-Positive Breast Cancer Patients?
por: Payandeh, Mehrdad, et al.
Publicado: (2017)

MRI for breast cancer: Current indications
por: Ojeda-Fournier, Haydee, et al.
Publicado: (2009)

Computational prognostic indicators for breast cancer
por: Yang, Xinan, et al.
Publicado: (2014)

Molecular basis of breast cancer with comorbid depression and the mechanistic insights of Xiaoyaosan in treating breast cancer-associated depression
por: Chen, Gang
Publicado: (2023)

Management of breast cancer brain metastases: Focus on human epidermal growth factor receptor 2-positive breast cancer
por: Yuan, Peng, et al.
Publicado: (2017)

Increasing our understanding of dying of breast cancer: Comorbidities and care
por: Johnston, G.M., et al.
Publicado: (2016)

The association between comorbidities and stigma among breast cancer survivors
por: Zhang, Yuxin, et al.
Publicado: (2022)

Bioinformatics and network biology approach to identifying type 2 diabetes genes and pathways that influence the progression of breast cancer
por: Sarkar, Md Sumon, et al.
Publicado: (2023)

Advanced breast cancer
por: Naqos, Nora
Publicado: (2018)

Understanding breast cancer risk factors: is there any mismatch between laywomen perceptions and expert opinions
por: Manouchehri, E., et al.
Publicado: (2022)

Baseline cardiovascular comorbidities, and the influence on cancer treatment decision-making in women with breast cancer
por: Subramaniam, Shridevi, et al.
Publicado: (2021)

Breast Cancer Following Multiple Fluoroscopies
por: Mackenzie, I.
Publicado: (1965)

Comorbidity and survival of Danish breast cancer patients from 1995 to 2005
por: Cronin-Fenton, D P, et al.
Publicado: (2007)

Haptoglobin Genotypes and Malaria Comorbidity in Breast Cancer and Healthy Nigerian Women
por: Dokunmu, Titilope M., et al.
Publicado: (2022)

Znhit1 and HIF-2α are correlated with cancer stem cell markers in breast cancer patients
por: Ebeid, Samia A., et al.
Publicado: (2022)

Potential misinterpretations caused by collapsing upper categories of comorbidity indices: An illustration from a cohort of older breast cancer survivors
por: Ahern, Thomas P, et al.
Publicado: (2009)

Epidermal growth factor receptor status of histological sub-types of breast cancer.
por: Sainsbury, J. R., et al.
Publicado: (1988)

Colocalization of somatostatin receptors and epidermal growth factor receptors in breast cancer cells
por: Watt, Heather L, et al.
Publicado: (2006)

Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancer
por: Henson, Elizabeth S, et al.
Publicado: (2007)

Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer
por: Kim, Aeri, et al.
Publicado: (2017)

Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer
por: Yang, ZiYan, et al.
Publicado: (2021)

Fat Necrosis of the Breast After Coronary Artery Bypass Grafting Presenting Similarly to Inflammatory Breast Cancer
por: Horne, Caroline G, et al.
Publicado: (2022)

Future possibilities in the prevention of breast cancer: Role of genetic variation in breast cancer prevention
por: Feigelson, Heather Spencer, et al.
Publicado: (2000)

Epidermal growth factor receptor (EGFR) gene alteration and protein overexpression in Malaysian triple-negative breast cancer (TNBC) cohort
por: Zakaria, Zubaidah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2vdl6dfve2uhilak328q85li3p